Question 1

What are the potential side effects of brodalumab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Brodalumab (AMG 827) in Adults With Moderate to Severe Crohn's Disease clinical trial (NCT01150890). Contact the study team or your healthcare provider for specific answers.

Question 2

How does brodalumab compare to other treatments I am currently considering?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Brodalumab (AMG 827) in Adults With Moderate to Severe Crohn's Disease clinical trial (NCT01150890). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the treatment process look like, including how often I would need to come in for infusions?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Brodalumab (AMG 827) in Adults With Moderate to Severe Crohn's Disease clinical trial (NCT01150890). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific tests or evaluations I would need to undergo before starting this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Brodalumab (AMG 827) in Adults With Moderate to Severe Crohn's Disease clinical trial (NCT01150890). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Brodalumab (AMG 827) in Adults With Moderate to Severe Crohn's Disease clinical trial (NCT01150890). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be monitored throughout the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Brodalumab (AMG 827) in Adults With Moderate to Severe Crohn's Disease clinical trial (NCT01150890). Contact the study team or your healthcare provider for specific answers.

What this study is about